comparemela.com

Latest Breaking News On - Caroline ruda shutterstock - Page 1 : comparemela.com

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

A recent study in Nature Medicine shows semaglutide reduces kidney risks in non-diabetic obese patients with cardiovascular disease by 22%. The SELECT trial results highlight semaglutide's benefits for kidney function and overall cardiovascular health.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.